Respiratory bacteria can 'turn off' the immune system
A research team led by The University of Queensland (UQ) has identified how a common bacterium is able to cause persistent respiratory illness via the unique ability to ‘talk to’ and deactivate the immune system, convincing it there is no threat. Their work has been published in the journal PLOS Pathogens.
The researchers, led by Professor Ulrike Kappler from UQ’s School of Chemical and Molecular Biosciences, studied the virulence mechanisms of Haemophilus influenzae — a bacterium that plays a significant role in worsening respiratory tract infections. Kappler noted that these bacteria are especially damaging to vulnerable groups, such as those with cystic fibrosis, asthma, the elderly and Indigenous communities.
“In some conditions, such as asthma and chronic obstructive pulmonary disease, they can drastically worsen symptoms,” she said.
“Our research shows the bacterium persists by essentially turning off the body’s immune responses, inducing a state of tolerance in human respiratory tissues.”
Kappler and the team prepared human nasal tissue in the lab, growing it to resemble the surfaces of the human respiratory tract, then monitored gene expression changes over a 14-day ‘infection’. They found limited production of inflammation molecules over time, which normally would be produced within hours of bacteria infecting human cells.
“We then applied both live and dead Haemophilus influenzae, showing the dead bacteria caused a fast production of the inflammation makers, while live bacteria prevented this,” Kappler said.
“This proved that the bacteria can actively reduce the human immune response.”
Co-author Emeritus Professor Peter Sly, from UQ’s Faculty of Medicine, said the results show how Haemophilus influenzae can cause chronic infections, essentially living in the cells that form the surface of the respiratory tract.
“This is a rare behaviour that many other bacteria don’t possess,” Sly said.
“If local immunity drops, for example during a viral infection, the bacteria may be able to ‘take over’ and cause a more severe infection.”
The findings will lead to future work towards new treatments to prevent these infections by helping the immune system to recognise and kill these bacteria. According to Kappler, “We’ll look at ways of developing treatments that enhance the immune system’s ability to detect and eliminate the pathogen before it can cause further damage.”
TGA rejects Alzheimer's drug due to safety concerns
The TGA determined that the demonstrated efficacy of lecanemab in treating Alzheimer's did...
Defective sperm doubles pre-eclampsia risk in IVF patients
A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...
Free meningococcal B vaccines coming to the NT
The Northern Territory Government has confirmed the rollout of a free meningococcal B vaccine...